These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23573603)

  • 1. Recent evidence for dopamine abnormalities in schizophrenia.
    Abi-Dargham A
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():341s-347s. PubMed ID: 23573603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dopaminergic hypothesis revisited].
    Guillin O
    Encephale; 2006 Oct; 32(5 Pt 4):S908-11; discussion S912. PubMed ID: 17119503
    [No Abstract]   [Full Text] [Related]  

  • 4. [PET (positron emission tomography) research on schizophrenia].
    Takano A; Suhara T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):177-83. PubMed ID: 16971782
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
    Cumming P; Abi-Dargham A; Gründer G
    Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
    Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging of schizophrenia--the dopamine hypothesis.
    Farde L
    Schizophr Res; 1997 Dec; 28(2-3):157-62. PubMed ID: 9468350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal dopamine D1 receptors and working memory in schizophrenia.
    Abi-Dargham A; Mawlawi O; Lombardo I; Gil R; Martinez D; Huang Y; Hwang DR; Keilp J; Kochan L; Van Heertum R; Gorman JM; Laruelle M
    J Neurosci; 2002 May; 22(9):3708-19. PubMed ID: 11978847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G; LeDuc PA; Whishaw IQ
    Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With Schizophrenia.
    Horga G; Cassidy CM; Xu X; Moore H; Slifstein M; Van Snellenberg JX; Abi-Dargham A
    JAMA Psychiatry; 2016 Aug; 73(8):862-70. PubMed ID: 27145361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Farde L; Karlsson P; Nyberg S; Nordström AL
    Isr J Psychiatry Relat Sci; 1995; 32(1):22-9. PubMed ID: 7622344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
    Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
    Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
    Busatto GF; Pilowsky LS; Ell PJ; Costa DC; Verhoeff NP; Kerwin RW
    Br J Psychiatry; 1993 Dec; 163():833-4. PubMed ID: 7508329
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
    Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
    Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.
    Yang YK; Yeh TL; Chiu NT; Lee IH; Chen PS; Lee LC; Jeffries KJ
    Psychiatry Res; 2004 Sep; 131(3):209-16. PubMed ID: 15465290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.